Ignite Creation Date:
2025-12-24 @ 9:46 PM
Ignite Modification Date:
2025-12-31 @ 3:54 AM
Study NCT ID:
NCT05687032
Status:
COMPLETED
Last Update Posted:
2025-12-03
First Post:
2023-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-06
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-06
First Submit QC Date:
None
Study First Post Date:
2023-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-07-22
Results First Submit QC Date:
None
Results First Post Date:
2025-08-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-27
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED